Search All News
New technology will allow scientists to uncover what happens in the brain during the early stages of Parkinson's disease, which could lead to earlier diagnosis and better therapies for the disease.
Only select neurons die during Parkinson’s disease. Columbia researchers are looking for clues in immune cells to find out what makes these brain cells so vulnerable.
With several targeted Parkinson’s disease drugs entering clinical trials, a new genetic testing and counseling program may help identify patients who qualify for enrollment.
Columbia neurologists and engineers are using a robotic device to investigate how Parkinson’s affects the ability to walk and respond to balance perturbations.
- December 8, 2004
Columbia University Medical Center part of multi-center trial that may resolve controversy over most effective Parkinson therapy.